Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Change in Acquisitions & Divestments: 2018-2025

Historic Change in Acquisitions & Divestments for Neurogene (NGNE) over the last 3 years, with Sep 2025 value amounting to $99.5 million.

  • Neurogene's Change in Acquisitions & Divestments rose 1037.14% to $99.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $227.9 million, marking a year-over-year increase of 260.40%. This contributed to the annual value of $74.0 million for FY2024, which is 1380.00% up from last year.
  • As of Q3 2025, Neurogene's Change in Acquisitions & Divestments stood at $99.5 million, which was up 46.32% from $68.0 million recorded in Q2 2025.
  • Over the past 5 years, Neurogene's Change in Acquisitions & Divestments peaked at $99.5 million during Q3 2025, and registered a low of $5.0 million during Q4 2023.
  • Over the past 3 years, Neurogene's median Change in Acquisitions & Divestments value was $24.8 million (recorded in 2024), while the average stood at $36.4 million.
  • Data for Neurogene's Change in Acquisitions & Divestments shows a peak YoY surged of 1,037.14% (in 2025) over the last 5 years.
  • Over the past 3 years, Neurogene's Change in Acquisitions & Divestments (Quarterly) stood at $5.0 million in 2023, then soared by 215.00% to $15.8 million in 2024, then surged by 1,037.14% to $99.5 million in 2025.
  • Its last three reported values are $99.5 million in Q3 2025, $68.0 million for Q2 2025, and $44.7 million during Q1 2025.